Today SynGenSys announced the launch of NK.SET™, the first commercially available NK (natural killer) cell-specific promoter library enabling precise and controllable gene expression. Read the full press release here: www.syngensys.com/resources/nk

Today Atelerix announced it has entered into a new distribution agreement with CliniSciences, a leading European player in the distribution and development of solutions for research and diagnostics, improving access to its non-cryogenic cell preservation solutions. Read more: shorturl.at/uFlyo

Today @trimtechtx.bsky.social announced it has been named as one of Fierce Biotech’s ‘Fierce 15’ for 2025. The company is creating novel, aggregate-selective, targeted protein degraders to combat neurodegenerative and inflammatory diseases such as Alzheimer’s. Read more: shorturl.at/IRTJO

Today Closed Loop Medicine announced the U.S. launch of WeDosify, the Company’s first commercially available product, which enables clinicians to personalize GLP-1 titration at scale. Read more: www.closedloopmedicine.com/closed-loop-...

Today @enhancedgenomics.bsky.social announced it has completed a financing round, extending its total Series A funding to $19 million. The funding will be used to drive therapeutics discovery in common diseases with high unmet medical need. Read more: shorturl.at/xQdeb

Today FUJIFILM Biosciences introduced BalanCD HEK293 Perfusion A Medium, the first commercially available cell culture solution that uses a suspension of HEK293 cell and perfusion technology to streamline production of viral vectors for gene therapies. bit.ly/465mAj1

@eppendorf.bsky.social has introduced next generation mechanical pipettes. The Eppendorf Research 3 neo pipette is designed to deliver accurate and precise results for accelerated volume selection and optimised ergonomics and is now available in Asia, EMEA and the Americas. bit.ly/46lc0ED

Today, Atelerix has announced a new agreement with Rodon Global to broaden access to safe shipping and storage solutions for temperature-sensitive biomaterials, without freezing. Read the full release: bit.ly/3JGIK2t

Today @trimtechtx.bsky.social announced the formation of its Scientific Advisory Board (SAB). Professor Alessio Ciulli and Dr Adam Gilbert have been appointed as Chair and member of the SAB, respectively. Read the full press release here: shorturl.at/f76pR

Today, CN Bio announced an expansion to its Contract Research Services ADME portfolio with the addition of computational modelling capabilities to unlock deeper understanding of key ADME parameters Read more: bit.ly/4mIo7Bx

Today Qureight announced the appointment of Craig Rhodes as Head of Partnerships. Craig will lead on pharma partner relationship management and support the integration of Qureight’s platform into clinical trial workflows to advance understanding of lung & heart diseases. bit.ly/4naAohX

Today Qureight announced that its AI 3D imaging platform will be used to support Calluna Pharma’s Phase 2 study of CAL101 in Idiopathic Pulmonary Fibrosis (IPF). The platform quantifies anatomical lung changes, providing insights into treatment efficacy. bit.ly/4lQjDrj

Bio-Rad Laboratories today announced a new range of StarBright Dyes, providing greater choice and flexibility for spectral flow cytometry in immunology research. StarBright UltraViolet700 is now available, marking the start of a broader rollout over the coming months: www.bio-rad.com/en-uk/life-s...

Bio-Rad Laboratories has launched the EZ-Check Salmonella spp. Kit for the detection of Salmonella in food and environmental samples. The kit has also been approved by AOAC International and certified NF Validation by AFNOR Certification. Read more: www.bio-rad.com/en-uk/life-s...

Camena Bioscience and Constructive Bio today announced they have joined a collaborative project led by the Max-Planck Institute of Molecular Plant Physiology, for a research initiative to develop synthetic chloroplast genomes. Read more here: rb.gy/s7s7aq

Sunil Shah (CEO, o2h Ventures) and Dr Catherine Elton (CBO, Axol Bioscience) join Atelerix's Board to drive commercial expansion and broaden access to the Company’s cell preservation solutions across major markets. Read the full press release: bit.ly/45Joe9M

Today @antibodies-dot-com.bsky.social announced the expansion of its UK headquarters with new larger facilities in Cambridge to accommodate rapid growth. This increases the Company’s operational capabilities and broadens access to its high-quality reagents and products. bit.ly/3GXPMim

Centauri Therapeutics announces an additional $5.1M funding from CARB-X to progress the lead compound in its ABX-01 programme to first in human clinical trials. Read the full release: shorturl.at/gDYAo

Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial to further evaluate safety and efficacy of lead candidate ENX407 in patients with non-proliferative diabetic retinopathy. Read the full release: shorturl.at/RuxNd

PhoreMost today announced the appointment of Dr Adam Gilbert to its SAB. Adam will support PhoreMost to advance its portfolio of novel degrader therapeutics, and oversee the translation of molecular glues arising from its GlueSEEKER platform. More: shorturl.at/Y4Ciy

PhoreMost published a new study showcasing the capabilities of its high-throughput GlueSEEKER® platform to accelerate the design and development of novel molecular glue degraders. Read more ➡️https://shorturl.at/R9tbG

Qureight today announced results from a collaboration with Insilico Medicine which used Qureight’s deep-learning image biomarkers and clinical data analytics platform to analyse enrolled IPF patient data, supporting rentosertib efficacy outcome and study expansion. More here: rb.gy/2ed7et

OMED Health, part of Owlstone Medical, has launched OMED Health Plans: personalized treatments and services to help patients gain control of their functional gastrointestinal conditions. The new plans include the diagnosis of SIBO and IMO. Read more: www.owlstonemedical.com/about/news/2...

Centauri Therapeutics appoints Dr Debra Barker as Chief Medical Officer to guide clinical strategy, advance development pipelines and help progress the Company’s lead candidate through to Phase I clinical trials. Read more: shorturl.at/C0x8y

Today @sptlabtech.bsky.social and Semarion announced a collaboration. Integrating SPT Labtech’s firefly liquid handling platform with Semarion’s SemaCyte microcarrier technology the partnership will advance automated workflows to streamline adherent cell assay development. rb.gy/tzjxvw

Today Optibrium announced that it has secured a multi-million-pound financing package from Shawbrook. The funding will be used to support improvements of the Company’s core technologies, build technical capabilities and support further global expansion. More: bit.ly/4nDzWK8

Today SolasCure announced the publication of a peer-reviewed study in the International Wound Journal. Building on positive Phase IIA clinical findings, the study reinforces Aurase Wound Gel's favourable safety profile and pain-free application. More: shorturl.at/ilgYJ

Bio-Rad Laboratories today announced the launch of four new Droplet Digital™ PCR (ddPCR™) platforms. The instruments include Bio-Rad’s QX Continuum™ and the QX700™ series of platforms acquired as part of the recent acquisition of digital PCR developer Stilla Technologies. More here: rb.gy/02xjw7

Today Optibrium announced a partnership with TalTech to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme. The PhD research will focus on developing faster and more accurate methods for predicting drug metabolism More: bit.ly/4l6uPQR

4basebio introduces new branding to reflect the Company's next phase of growth on its mission to deliver scalable, high-quality synthetic DNA solutions to the global market. Read the full press release: bit.ly/3I61eZm

Today Shift Bioscience announced the results of a new study detailing an improved approach to ranking virtual cell models for gene discovery. Read more: rb.gy/l98dbw

📣 Today marks 15 years since Zyme was founded, and we're proud to have built a strong global life science network, driven by a dedicated team of passionate scientists & communications specialists. To celebrate, we’ve introduced a refreshed look! ➡ bit.ly/4nll7eU

Today @enhancedgenomics.bsky.social announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge to identify multiple novel therapeutic targets for Alzheimer's disease using Enhanced’s 3D multi-omics platform. More: rb.gy/1fuxfw

OutSee raises £1.8M seed funding to expand and progress the Company's in-house target development program using its proprietary AI-based predictive genomics technology, Nomaly. Read more: bit.ly/45Dilvo

Bio-Rad is expanding its portfolio of anti-idiotypic antibodies and SpyCatcher reagents—supporting robust, reliable bioanalytical assays and enabling therapeutic drug monitoring for innovator and biosimilar biologics. Read more: rb.gy/gys3i6

Qureight today announced that its digitally-twinned synthetic control arm has been used in a breakthrough #clinicaltrial application in place of a human placebo group. The study demonstrates significant clinical efficacy for Avalyn’s inhaled pirfenidone (AP01). Read more here: rb.gy/udj4dj

@sphere-bio.bsky.social has expanded its operations in China. The Company has selected Redbert Biotechnology as its exclusive distribution partner and appointed Johnathan Fu as China Distribution Manager to lead regional partnerships and enhance customer support. More: bit.ly/445FC6K

Mursla Bio has introduced its AI Precision Medicine Platform. Through extracellular vesicle isolation from blood, the Platform enables differentiated AI-powered biomarker discovery. Published pre-print data demonstrates its capability in liver disease. bit.ly/3TwgssQ

Today SolasCure announced that the FDA has granted Fast Track Designation for its investigational Aurase Wound Gel, in the treatment of patients with calciphylaxis ulcers, widening its application in the healing of chronic wounds. Read more: rb.gy/zyb2qo

Kadans Science Partner has completed construction of the primary structure of Merlin Place, Cambridge, a purpose-built laboratory facility designed to encourage collaboration and advance life sciences and health innovation. Read more: www.kadans.com/news/structu...

This week, Tagomics has been awarded £860k @innovateuk.bsky.social funding as part of the Biomedical Catalyst grant for a £1.2M project to customise its multiomic profiling platform, Interlace, for the early detection of colorectal cancer. Read more: tagomics.com/tagomics-awa...

Centauri Therapeutics has published a peer-reviewed study in the Journal of Immunology, presenting the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infections. Read the full press release: rb.gy/2a8n5q

enhancedgenomics.bsky.social today announced the appointment of Dietrich Stephan, Ph.D. as Chair of the Board to lead the management team in implementing the Company’s strategic plans to drive expansion of its internal target identification pipeline and establish strategic partnerships➡️ rb.gy/ynmvz7

Today CN Bio introduced cross species DILI services to its Contract Research Services. Extending the capabilities of the Company’s PhysioMimix DILI assay, these services will enhance in vitro to in vivo extrapolation during preclinical drug development. bit.ly/3TigTHc

Today Shift Bioscience announced the publication of new research identifying a novel single-gene target for cellular rejuvenation. SB000 reverses cellular aging across multiple cell types without inducing dangerous pluripotency pathways. Learn more➡️https://rb.gy/sweg7z

Fujifilm has announced a rebranding for its Life Science Companies, including FUJIFILM Irvine Scientific and FUJIFILM Diosynth Biotechnologies, to strengthen the Companies' positions as strategic partners for life. Read the full press release: bit.ly/3T8txs8

Today Nuclera announced a collaboration with Cytiva. This collaboration combines Nuclera’s eProtein Discovery with Cytiva’s Biacore SPR system to accelerate the synthesis and characterisation of proteins implicated in drug development. More: eprote.in/Colab

Today @sapiosciences.bsky.social announced the appointment of Gordon McCall as Chief Operating Officer. Gordon will lead global customer delivery teams, manage customer relationships, and oversee operational functions to drive excellence in customer delivery and satisfaction. bit.ly/4kDzPvP

Today Closed Loop Medicine announced the appointment of Kate Woolland as CEO, stepping into the role as the company shifts its focus to strategic commercial deployment and scaling of its precision dosing technologies. Read more: rb.gy/o2wp56

Shift Bioscience appoints Lord David Prior, previously Chairman of NHS England, and Sir Tony Kouzarides, co-founder of the Milner Therapeutics Institute and Abcam, to support long-term strategy for cell rejuvenation therapeutics. Read the full press release: bit.ly/4kpyad5